31 results
424B5
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement for primary offering
4:52pm
and supplier upon FDA approval of our product candidate. We have not determined the amounts we plan to spend on the areas listed above or the timing
8-K
EX-1.1
6gjble7gpjzm3
13 Dec 21
Entry into a Material Definitive Agreement
9:23am
424B5
r3bsbqd7zwn101r 9w
13 Dec 21
Prospectus supplement for primary offering
9:19am
424B5
4nabnr9mlfeus
10 Dec 21
Prospectus supplement for primary offering
5:25pm
424B5
hnufgu
10 Nov 21
Prospectus supplement for primary offering
5:25pm
8-K
EX-1.1
7osvrui2tyj6y28rfkp
10 Nov 21
Entry into a Material Definitive Agreement
5:22pm
424B5
swdowl9q2ai 84r
9 Nov 21
Prospectus supplement for primary offering
5:14pm